MedPath

Strength training as a complementary treatment in the immune system of people living with HIV/Aids: clinical and randomized trial.

Not Applicable
Recruiting
Conditions
enfermedad por el virus de la inmunodeficiencia humana (HIV)
B20-B24
Registration Number
RBR-9znxcq
Lead Sponsor
niversidade Federal de Pernambuco
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals receiving the first antiretroviral regimen; undetectable viral load in the last six months; CD4+cell counts> 200 u/L in the last six months; use of antiretroviral therapy for more than six months; low risk of ischemic cardiac event Framingham; To have an adequate physical condition.

Exclusion Criteria

Disorders of locomotion; mental disorders, except anxiety and depression; continuous use of depressant drugs of the Central Nervous System (CNS), except benzodiazepine, use of statins, use of corticosteroids; use of non-hormonal anti-inflammatory drugs; pregnancy or breastfeeding; severe renal and / or hepatic and / or cardiopulmonary disease.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Increased anti-inflammatory cell level and low level of pro-inflammatory cells of the immune system of people living with HIV/Aids. It will be checked by flow cytometry. Where the measurements of each item will be performed three times, the first at the beginning of the project, the second after 18 sessions and the last after 36 training sessions.<br><br>
Secondary Outcome Measures
NameTimeMethod
Increased muscle mass and decreased body fat level will be employed the technique of dual beam x-ray absorptiometry (DXA). As well as the decreased levels of fat in the blood (Atherosclerosis), which will be performed through the ultrasound of the carotid artery. Where the measurements of each item will be performed three times, the first at the beginning of the project, the second after 18 sessions and the last after 36 training sessions.<br><br>
© Copyright 2025. All Rights Reserved by MedPath